| Positive Rankings |
Low vPut/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.29 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 696. |
Debt-to-Equity
Syndax Pharmaceuticals rank is 717 |
Up EPS Surprise
Syndax Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings. |
Low Put/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.53 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 1250. |
Price-to-Book
Syndax Pharmaceuticals rank is 2054 |
| Negative Rankings |
Negative Net Margin
Syndax Pharmaceuticals rank is 102 |
Price-to-Sales
Syndax Pharmaceuticals rank is 151 |
Negative ROE
Syndax Pharmaceuticals rank is 537 |
Negative ROA
Syndax Pharmaceuticals rank is 573 |
90 Day Loss
Syndax Pharmaceuticals rank is 842 |
10 Day Loss
Syndax Pharmaceuticals rank is 935 |
